Medications


The Antiviral Effect On COVID

Gilead Sciences, Inс has published topline outcomes from the Phase 3 SIMPLE trial in hospitalized sufferers with COVID infection. This open-label research estimated 5-day and…




Cholesterol Lowering Bacteria

The investigation into the nature of inequalities in the gut microbiome has revealed that the combination of gut microbes is connected to human diseases that…


Heart Failure Medication Approved

The FDA has awarded a further implication for dapagliflozin (Farxiga, AstraZeneca Pharmaceuticals), heart failure medication, the first sodium-glucose co-transporter 2 (SGLT2) inhibitor to be allowed…



A New NYU Investigation vs. COVID-19

The analysis from New York University (NYU) Grossman School of Medicine has discovered no link between therapy with four medication classes—angiotensin-converting enzyme (ACE) inhibitors, angiotensin…